India’s drug regulatory authority has issued a warning to the public regarding two cosmetic products manufactured in Pakistan after testing revealed high levels of heavy metals. The Central Drugs Standard Control Organisation announced on September 8 that Goree Beauty Cream and Chandni Whitening Cream are not authorized for sale in India. Both items bear labels indicating they were produced in Pakistan. The regulator clarified that neither product had approval for import or distribution within India and warned that the excessive heavy metal content could lead to toxic effects and health hazards.

According to the World Health Organization, Ebola transmission is decreasing in several of the most affected regions of the Democratic Republic of the Congo. This positive trend is especially noticeable in parts of Ituri province, which remains the epicenter of the outbreak. Nevertheless, the epidemic continues to spread in other areas. Data up to Sept. 13 indicates a total of 7,258 confirmed cases and 3,510 fatalities across seven provinces, with the overall case fatality ratio at 48.4%.DR Congo’s Ebola response continues as health teams track changing transmission patterns.

Legionella DNA was found during initial testing of a cooling tower at Yankee Stadium as New York City probes a cluster of Legionnaires’ disease cases in the South Bronx. By Tuesday evening, authorities confirmed 11 cases, including one fatality. Three individuals remain hospitalized. The New York City Health Department identified 10 cooling towers with positive preliminary PCR results across ZIP codes 10451 and 10456, which encompass parts of Melrose and Morrisania.

Healthcare workers in protective gear manage patient isolation areas inside treatment facilities. In response to the geographical spread, authorities adopted a decentralized treatment approach to establish healthcare facilities closer to rural communities affected by the outbreak. Nearly 1,400 treatment beds have been set up across 59 specialized operational centers by response teams. However, assessments indicate that an additional 1,600 beds are needed to reach the targeted capacity of 3,000 beds. Achieving this expansion will require recruiting and training about 5,000 more healthcare professionals to support the current 9,000 health workers necessary for full operational readiness. Limited operational funds and resource constraints have further hindered efforts to expand field operations in remote provinces. On average, daily needs for personal protective equipment are $25 per healthcare worker entering high-risk patient isolation zones. Running a standard 50-bed treatment facility demands around $500,000, posing significant financial difficulties amid decreasing global donor funding. Data shared via the Emirates News Agency highlights that fully operational treatment centers and adequately trained personnel remain essential for improving patient survival and halting virus transmission. Staffing Shortages and Funding Challenges Slow Ebola Response in Congolese Provinces One of the main structural obstacles is the ongoing shortage of non-governmental partners capable of managing complex isolation facilities. Luca Fontana, the WHO technical lead, pointed out that only five or six global humanitarian organizations possess the expertise required to establish and operate specialized Ebola treatment centers. Without additional operational partners to take over existing sites, technical teams remain tied to

Congo’s Ebola response expands as Bundibugyo transmission remains active. This outbreak has become both Congo’s largest and most lethal Ebola episode on record. It also ranks as the second-largest Ebola outbreak worldwide, following the 2014-2016 epidemic in West Africa. Ituri remains at the epicenter of the crisis, accounting for roughly 85% of cases and 88% of deaths. Tedros highlighted that many deaths involve individuals not registered as known contacts, indicating ongoing gaps in identifying transmission chains. Challenges such as community deaths and unsafe burials continue to hinder containment efforts. According to Africa CDC, over 60% of fatalities during the most recent seven-day period occurred in community settings. Health authorities have also reported delays in early detection and in transporting patients to treatment centers. Recent government data shows 1,439 recoveries and a case fatality rate of 48.6%, underscoring the severity of the Bundibugyo strain. Ongoing transmission in eastern Congo Even though recent weeks have seen some signs of case decline, transmission persists in 51 health zones. Four zones have not reported new cases for over 42 days and have halted transmission. Additionally, five zones have experienced between 21 and 42 days without new infections. Officials have warned that this decrease is too recent to confirm that the Ebola outbreak nationwide is under control. To combat the outbreak, the WHO has ramped up testing, treatment, and field operations in affected regions. Over 330 tonnes of

In Kisangani, the capital of Tshopo Province, health authorities in the Democratic Republic of the Congo have launched a targeted Ebola immunization campaign to stem the deadliest outbreak in the country’s history. Frontline healthcare workers, emergency response teams, and individuals with direct contact to confirmed cases are being prioritized during the initial deployment phase. Health Minister Roger Kamba confirmed that the government has begun using doses of the Ervebo vaccine to protect front-line personnel working in the affected eastern regions.